Elevated plasma adiponectin levels in patients with chronic obstructive pulmonary disease

International Journal of Tuberculosis and Lung Disease

Volumn 14, Issue 9, 2010, Pages 1193-1200

  Chan, K H ^a   Yeung, S C ^a   Yao, T J ^b   Ip, M S M ^a   Cheung, A H K ^a   Chan Yeung, M M W ^a   Mak, Judith C W ^a,b   Lam, W K ^c,m   Yew, W W ^d   Wong, P C ^d   Chau, C H ^d   Liu, R ^e   Lam, C W ^e   So, L ^f   Yee, W ^g   Chan, K K ^h   Chan, K S ^h   Chan, J W M ⁱ   Chu, C M ^j   Ho, A S S ^k   Sit, K M ^l   Choo, K ^m   Ko, F W S ⁿ   Yu, W C ^o   Wong, M ^p   more..

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b UNIVERSITY OF HONG KONG   (Hong Kong)

^c QUEEN MARY HOSPITAL   (Hong Kong)

^d GRANTHAM HOSPITAL   (Hong Kong)

^e Ruttonjie Hospital   (Hong Kong)

^f PAMELA YOUDE NETHERSOLE EASTERN HOSPITAL   (Hong Kong)

^g KWONG WAH HOSPITAL   (Hong Kong)

^h Haven of Hope Hospital   (Hong Kong)

ⁱ QUEEN ELIZABETH HOSPITAL   (Hong Kong)

^j UNITED CHRISTIAN HOSPITAL   (Hong Kong)

^k ALICE HO MIU LING NETHERSOLE HOSPITAL   (Hong Kong)

^l TUEN MUN HOSPITAL   (Hong Kong)

^m NORTH DISTRICT HOSPITAL   (Hong Kong)

ⁿ CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^o PRINCESS MARGARET HOSPITAL   (Hong Kong)

^p Caritas Medical Centre Hong Kong   (Hong Kong)

more..

Author keywords

Adiponectin; C reactive protein; Chronic obstructive pulmonary disease; Interleukin 6; Interleukin 8; Lung function

Indexed keywords

ADIPONECTIN; C REACTIVE PROTEIN; INTERLEUKIN 6; INTERLEUKIN 8;

ADULT; AGED; ARTICLE; BLOOD LEVEL; BODY MASS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; FORCED EXPIRATORY VOLUME; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; METABOLIC SYNDROME X; PRIORITY JOURNAL; SMOKING; STATISTICAL ANALYSIS;

ADIPONECTIN; ADULT; AGED; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CROSS-SECTIONAL STUDIES; DATABASES, FACTUAL; FORCED EXPIRATORY VOLUME; HUMANS; INTERLEUKIN-6; INTERLEUKIN-8; MALE; MIDDLE AGED; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SMOKING;

EID: 77956594638     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Murray C J, Lopez A D. Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study. Lancet 1997; 349: 1498-1504.
2. Pauwels R A, Buist A S, Calverley P M, Genkins C R, Hurd S S; GOLD Scientific Committee. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO global initiative for chronic obstructive pulmonary disease (GOLD) workshop summary. Am J Respir Crit Care Med 2001; 163: 1256-1276.
3. Sethi J M, Rochester C L. Smoking and chronic obstructive pulmonary disease. Clin Chest Med 2000; 21: 67-86.
4. Kolsum U, Roy K, Starkey C, et al. The repeatability of interleukin-6, tumor necrosis factor-alpha, and C-reactive protein in COPD patients over one year. Int J Chron Obstruct Pulmon Dis 2009; 4: 149-156.
5. Keatings V M, Collins P D, Scott D M, Barnes P J. Differences in interleukin-8 and tumor necrosis factor-alpha in induced sputum from patients with chronic obstructive pulmonary disease or asthma. Am J Respir Crit Care Med 1996; 153: 530-534.
6. Yamamoto C, Yoneda T, Yoshikawa M, et al. Airway inflammation in COPD assessed by sputum levels of interleukin-8. Chest 1997; 112: 505-510. (Pubitemid 27349446)
7. Man S F, Connett J E, Anthonisen N R, Wise R A, Tashkin D P, Sin D D. C-reactive protein and mortality in mild to moderate chronic obstructive pulmonary disease. Thorax 2006; 61: 849-853.
8. Karadag F, Kirdar S, Karul A B, Ceylan E. The value of Cr eactive protein as a marker of systemic inflammation in stable chronic obstructive pulmonary disease. Eur J Int Med 2008; 19: 104-108.
9. Schraw T, Wang Z V, Halberg N, Hawkins M, Scherer P E. Plasma adiponectin complexes have distinct biochemical characteristics. Endocrinology 2008; 149: 2270-2282.
10. Kadowaki T, Yamauchi T, Kubota N, Hara K, Ueki K, Tobe K. Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome. J Clin Invest 2006; 116: 1784-1792.
11. Otero M, Lago R, Gomez R, et al. Changes in plasma levels of fat-derived hormones adiponectin, leptin, resistin and visfatin in patients with rheumatoid arthritis. Ann Rheum Dis 2006; 65: 1198-1201.
12. Rovin B H, Song H, Hebert L A, et al. Plasma, urine, and renal expression of adiponectin in human systemic lupus erythematosus. Kidney Int 2005; 68: 1825-1833. (Pubitemid 43169928)
13. Tomoda K, Yoshikawa M, Itoh T, et al. Elevated circulating plasma adiponectin in underweight patients with COPD. Chest 2007; 132: 135-140.
14. Kirdar S, Serter M, Ceylan E, Sener A G, Kavak T, Karadag F. Adiponectin as a biomarker of systemic inflammatory response in smoker patients with stable and exacerbation phases of chronic obstructive pulmonary disease. Scand J Clin Lab Invest 2009; 69: 219-224.
15. Summer R, Little F F, Ouchi N, et al. Alveolar macrophage a ctivation and an emphysema-like phenotype in adiponectin-deficient mice. Am J Physiol Lung Cell Mol Physiol 2008; 294: L1035-L1042.
16. Chan-Yeung M, Ho A S, Cheung A H, et al. Determinants of chronic obstructive pulmonary disease in Chinese patients in Hong Kong. Int J Tuberc Lung Dis 2007; 11: 502-507.
17. Rabe K F, Hurd S, Anzueto A, et al. Global initiative for chronic obstructive lung disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 2007; 176: 532-555.
18. American Thoracic Society. Standardization of spirometry. 1994 update. Am J Respir Crit Care Med 1995; 152: 1107-1136.
19. Ip M S, Ko F W, Lau A C, et al. Updated spirometric reference values for adult Chinese in Hong Kong and implications on clinical utilization. Chest 2006; 129: 384-392.
20. WHO Expert Consultation. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet 2004; 363: 157-163.
21. Ayerden Ebinç F, Ebinç H, Derici U, et al. The relationship between adiponectin levels and proinflammatory cytokines and left ventricular mass in dialysis patients. J Nephrol 2009; 22: 216-223.
22. Housova J, Anderlova K, Krizova J, et al. Serum adiponectin and resistin concentrations in patients with restrictive and binge/purge form of anorexia nervosa and bulimia nervosa. J Clin Endocrinol Metab 2005; 90: 1366-1370. (Pubitemid 40463989)
23. Plaisance E P, Grandjean P W, Judd R L, Jones K W, Taylor J K. The influence of sex, body composition, and nonesterified fatty acids on serum adipokine concentrations. Metabolism 2009; 58: 1557-1563.
24. Vernooy J H, Kucukaycan M, Jacobs J A, et al. Local and systemic inflammation in patients with chronic obstructive pulmonary disease: soluble tumor necrosis factor receptors are increased in sputum. Am J Respir Crit Care Med 2002; 166: 1218-1224.
25. Yamamoto C, Yoneda T, Yoshikawa M, et al. Airway inflammation in COPD assessed by sputum levels of interleukin-8. Chest 1997; 112: 505-510. (Pubitemid 27349446)
26. Rutgers S R, Timens W, Kaufmann H F, van der Mark TW, Koëter G H, Postma D S. Comparison of induced sputum with bronchial wash, bronchoalveolar lavage and bronchial biopsies in COPD. Eur Respir J 2000; 15: 109-115.
27. Higashimoto Y, Iwata T, Okada M, Satoh H, Fukuda K, Tohda Y. Serum biomarkers as predictors of lung function decline in chronic obstructive pulmonary disease. Respir Med 2009; 103: 1231-1238.
28. Yoshikawa T, Dent G, Ward J, et al. Impaired neutrophil chemotaxis in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2007; 175: 473-479.
29. Fietta A, Bersani C, De Rose V, et al. Evaluation of systemic host defense mechanisms in chronic bronchitis. Respiration 1988; 53: 37-43.
30. Kobashi C, Urakaze M, Kishida M, et al. Adiponectin inhibits endothelial synthesis of interleukin-8. Circ Res 2005; 97: 1245-1252.
31. Nan J L, Li J J, He J G. C-reactive protein decreases interleukin-8 production in human endothelial progenitor cells by inhibition of p38 MAPK pathway. Chin Med J 2009; 122: 1922-1928.
32. Yende S, Waterer G W, Tolley E A, et al. Inflammatory markers are associated with ventilatory limitation and muscle dysfunction in obstructive lung disease in well functioning elderly subjects. Thorax 2006; 61: 10-16.
33. Pinto-Plata V M, Mullerova H, Toso J F, et al. C-reactive protein in patients with COPD, control smokers and non-smokers. Thorax 2006; 61: 23-28.
34. Kishimoto T. The biology of interleukin-6. Blood 1989; 74: 1-10.
35. Camp P G, Coxson H O, Levy R D, et al. Sex differences in emphysema and airway disease in smokers. Chest 2009; 136: 1480-1488.
36. Wang Y, Lam K S, Yau M H, Xu A. Post-translational modifications of adiponectin: mechanisms and functional implications. Biochem J 2008; 409: 623-633.
37. Leung K-C, Xu A, Craig M E, Martin A, Lam K S, O'Sullivan A J. Adiponectin isoform distribution in women - relationship to female sex steroids and insulin sensitivity. Metab Clin Exp 2009; 58: 239-245.
38. Devaraj S, Swarbrick M M, Singh U, Adams-Huet B, Havel P J, Jialal I. CRP and adiponectin and its oligomers in the metabolic syndrome: evaluation of new laboratory-based biomarkers. Am J Clin Pathol 2008; 129: 815-822.